Nucleic acid amplification testing tests is extensively for screening and diagnosis of a wide range of infectious diseases as it detects the presence of viral DNAs or RNAs in blood samples of the patients. Furthermore, it is widely used in detection of cancer and genetic and mitochondrial disorders.
The global nucleic acid amplification testing market report has been segmented on the basis of technique, application, and region. Increasing number of cases of infectious diseases and growing use of nucleic acid amplification testing for detection of cancers are major factors expected to propel the market growth over the forecast period. Furthermore, continuous innovation in nucleic acid amplification testing by manufacturers is expected to drive the growth of global nucleic acid amplification testing market.
Based on technique, the market is segmented based on target amplification systems, probe amplification systems, and signal amplification. The target amplification systems segment contributes major market share and is expected to witness rapid growth rate over the forecast period. Target amplification systems includes use of PCR technique, increasing use of PCR technique is expected to contribute to the growth of target amplification systems segment as it is relatively inexpensive and simple.
Based on application, the market is segmented based on infectious diseases, cancer, personalized medicine, and genetic and mitochondrial disorders. The infectious disease contributes major market share. This is attributed due to the usage of nucleic acid amplification testing for detection of infectious diseases.
Do Inquiry of the Report Here: https://marketresearch.biz/report/nucleic-acid-amplification-testing-market/#inquiry
Based on region, the global nucleic acid amplification testing market is segmented into North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to the presence of large number of players the market and favorable reimbursement policies in the region. Asia Pacific is expected to witness rapid growth rate over the forecast period. This is attributed to the increasing number of prevalence of infectious diseases and developing healthcare infrastructure in the countries such as China and India.
Some prominent players in the global nucleic acid amplification testing market are Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Siemens Healthcare GmbH, Bio-Rad Laboratories, Inc., bioMérieux SA, Illumina, Inc., Grifols SA, Beckman Coulter, Inc., Abbott Laboratories, and Hologic, Inc.